Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 Yes. FCR In a message dated 13/02/2011 15:57:20 GMT Standard Time, zz646@... writes: Any Regimes seem to produce more durable results for the ATM or 11q deletion? Thanks, Skip Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 Thank you. I got a 50% node reduction after 6 cycles and rapid growth after just a few months...so looking for more options. Skip __________________ On Sun, Feb 13, 2011 at 11:48 AM, TERJOHA wrote: Yes. FCR __________________ Any Regimes seem to produce more durable results for the ATM or 11q deletion? Thanks, Skip __________________ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 One of the most important findings coming out of the German CLL Study Group 4 trial, and one of the few means iFISH has for altering therapy is that patients with deletion 11q did much better with FC versus F chemotherapy. As a result, deletion 11q patients are the one population I use FCR in. Rick Furman, MD > > Any Regimes seem to produce more durable results > for the ATM or 11q deletion? > > Thanks, > > Skip > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 I know that is the gold standard but I had virtually no response thru 3 cycles of FCR ...then we raised the R from the standard of 375 to 500 ....showed immediate reduction, yet at the end of the remaining 3 cycles ended with about 50% node reduction and was back to prechemo level after only 4-5 months of chemo holiday. Currently on Benda/Retux and it is working much better but still looking for fallback options...not optimistic this will be longlasting at the end of the full regime. On Sun, Feb 13, 2011 at 12:49 PM, rrfman wrote: One of the most important findings coming out of the German CLL Study Group 4 trial, and one of the few means iFISH has for altering therapy is that patients with deletion 11q did much better with FC versus F chemotherapy. As a result, deletion 11q patients are the one population I use FCR in. Rick Furman, MD Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 Dear Dr. Furman, Would you be kind enough to give us an update on Pci32765 and Cal 101? Are you still feeling as confident in the two kinase inhibitors? Thank you Re: Successful Chemo for 11q? Yes. FCR In a message dated 13/02/2011 15:57:20 GMT Standard Time, zz646@... writes: Any Regimes seem to produce more durable results for the ATM or 11q deletion? Thanks, Skip Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 You might want to look at HDMP and Rituxan. PubMed has a few articles. Kipps at UCSD designed the protocol, some hem/oncs use it locally. 11q is known for a shortened treatment response and poor prognosis. I have it too, and expect the same results you just obtained with FCR. Ann Re: Successful Chemo for 11q? Thank you. I got a 50% node reduction after 6 cycles and rapid growth after just a few months...so looking for more options. Skip __________________ On Sun, Feb 13, 2011 at 11:48 AM, TERJOHA wrote: Yes. FCR __________________ Any Regimes seem to produce more durable results for the ATM or 11q deletion? Thanks, Skip __________________ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 The best option for most patients in this setting would be a clinical trial. I remain very optimistic that CAL-101 and PCI-32765 (and others to come) will be the treatments of the future. Rick Furman > > One of the most important findings coming out of the German CLL > Study Group 4 trial, and one of the few means iFISH has for altering > therapy is that patients with deletion 11q did much better with FC > versus F chemotherapy. As a result, deletion 11q patients are the one > population I use FCR in. > > Rick Furman, MD > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 There is a misunderstanding about del 11q and treatment. It is the presence of rituxin in the treatment mix that makes the difference. The German CLL8 trial demonstrated that del 11q went from being a poor risk factor with FC to a standard risk factor with FCR. This is not to say that there are not some cases that will relapse rapidly (the median is not the message), but on average with FCR del 11q does no worse than trisomy 12 or a normal karyotype. There is no evidence that the presence of an alkylating agent makes any difference, but we have no data of FR versus F in this situation and no evidence that I know of that bendamustine works in this situation. I would expect the new enzyme inhibitors to be effective, but it is still early days in their development and they are only available in clinical trials. Terry Hamblin MD Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2011 Report Share Posted February 14, 2011 My question is: are the different responses we see, at least here on lists, due in part to different flavors of 11q? and in that case, IF known should FCR be considered differently in those patients ? While at dx I was pronounced 'lucky' to have gorgeous markers. As if any cancer can be termed thusly. That being said I was not surprised at slow steady rise in various whites, and same lowering of the reds, short hand here. However two years into this waiting game nodes proliferated, and grew. spleen became a problem. I began to read everything I could find and realized perhaps my 'markers' were no longer gorgeous. A novice CLL er then, I found all sorts of references to transformations into Richters. I concluded wrongly, that Richters was the " only " rock I might encounter. And that, usually after treatments.... so what WAS going on here? Boy was I wrong. More reading had me where I would have bet a dozen donuts that I had acquired an 11q deletion. I went about finding the broad array - big fish for those unfamiliar- and had it done. Not one but three different flavors of 11 were now messed up. I had also lost one copy of ATM... probably not both copies. While one is better than none, it seems to be an indication that this flavor of 11q is somewhat less stable than vanilla CLL or vanilla with nuts, (as in oh nuts) 11q with ATM in tact. I learned that my wbc/alc would probably remain a huge nothing for quite some time, but that the red team would probably start to leave their posts. All during this wait, however I would continue to grow more and bigger nodes, and perhaps spleen and liver, to say nothing of crowding out my marrow...It seems that 11q CLL progression is not so findable in routine blood tests. It's clinical performance however has become better known to us over time. Without ATM, or at least without Both copies, one has to rely on the other wide receiver, p53, and hope it gets the signal to kill and replace after treatment. Since this type of testing is relatively new, and not widely used, it will take time before anyone can answer these questions with any real certainty. My own report indicated a concern for a general instability, which tells me that treatment may not give me the gold standard results we've seen in studies. For sure this type of testing gives out more than we can use now. An incidental finding of a tri 8 is of somewhat dubious use to a CLL doctor, but told me that I probably had this 'pre leukemic' marker all along. Perhaps due to my early childhood radiation. Whatever the reason, it actually helped me to know. FISH would not have found the trisomy 8,(they don't FISH for it in CLL, Tri-8 is thought to be associated with mylodysplastic syndrome) Since two tries with FISH at major research centers had not found the 11q, none of them. nor the ATM. 11's are missed on fish many times. especially if they occur at the end of the piece. However it is entirely possible that mine may have morphed during that wait period. Whatever the case, I am glad I know now. they also found a 21q, which they state is at the moment of questionable value in evaluating cll. However since this type of testing covers the entire span, they are found. In other words, one doesn't need to know what one might find before looking. Perhaps in time, if this type of testing becomes more available, those other deletions will prove useful predictors as well, or perhaps explain the course of the disease origins. Storing that data is a simple matter. there are papers on this however they are PDF and can't be sent thru this list. There are also some on pay to read journals, however a google of 11q deletions in CLL, Gunn for starters, and go from there. Dr. Gunn IS affiliated with one lab who performs this test, but as I understand she has worked in concert with among others, Kipps, et al. I am not pushing any tests here. my point is that had I waited, content that my 'doubling time' and b symptoms were within tolerable ranges. and other such quick answers were NOT the whole story it's likely I would have been held in W and W and may have missed a chance to treat before I acquired still more deletions. My profile a year ago was not terribly stable, hence as I understand it, treatment could give me not much joy and bring on further deletions. Especially now that things are progressing more rapidly, I am not shocked. However I have serious doubts about FCR " just because " I happen to be an 11q kid. I've also had too many skin cancers and viral infections to want to go whole hog into particularly F. And from what I understand, any treatment at this point might eliminate my other copy of ATM, leaving me hoping that p53 is wide awake, and learns new tricks in time. So the dilemma, go see what joy I may find in FCR and then since I would have earned the coveted 'failed' status, be welcomed into a trial that required that status, tho perhaps in a worse place, or do nothing until one of the newer pups is ready for mass release. I may be off base here, but it seems a bit too easy to assume that ALL 11q's will respond the same way. As we have seen from posts repeatedly. No, the median is not the message, and if one is blessed with one deletion, perhaps there are others, or there will be. all the best ,,, beth fillman Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2011 Report Share Posted February 14, 2011 Thanks I will look into these...also hearing good things about Cal 101 but it is early stage. I got no response thru 3 cycles of FCR. The Rituxin was increased from 375 to 500mg and started getting immediate response--MD established this higher protocol. I'm now into 3rd cycle of Bendamustine/Rituxin and it is shrinking tumors from the first cycle...but again not expecting long duration until they begin to return. Good Luck -----Original Messages----- On Mon, Feb 14, 2011 at 3:25 AM, TERJOHA@... wrote: There is a misunderstanding about del 11q and treatment. It is the presence of rituxin in the treatment mix that makes the difference. The German CLL8 trial demonstrated that del 11q went from being a poor risk factor with FC to a standard risk factor with FCR. This is not to say that there are not some cases that will relapse rapidly (the median is not the message), but on average with FCR del 11q does no worse than trisomy 12 or a normal karyotype. There is no evidence that the presence of an alkylating agent makes any difference, but we have no data of FR versus F in this situation and no evidence that I know of that bendamustine works in this situation. I would expect the new enzyme inhibitors to be effective, but it is still early days in their development and they are only available in clinical trials. Terry Hamblin MD ____________________ The best option for most patients in this setting would be a clinical trial. I remain very optimistic that CAL-101 and PCI-32765 (and others to come) will be the treatments of the future. Rick Furman ________________________ You might want to look at HDMP and Rituxan. PubMed has a few articles. Kipps at UCSD designed the protocol, some hem/oncs use it locally. 11q is known for a shortened treatment response and poor prognosis. I have it too, and expect the same results you just obtained with FCR. Ann Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2011 Report Share Posted February 14, 2011 Craig, As another fellow with 11q del. I can tell you that from my experience, and based on my most recent understanding of the science, if you don't shrink the nodes all the way back to normal, and that includes the ones deep in the gut that only a CT or a very skilled sonogram can find, you are headed fro a short remission. 11q is already notorious for shorter remissions. HDMR + R or O is great for nodes, easy on the marrow, but very immune suppressive in the short term. I have seen long remissions with 11qer with this choice. A trial makes senses, especially as the new kinase inhibitors are very good with nodal disease. AT101 is also good with nodes and except for liver inflammation, seems pretty non-toxic Maybe you should be considering a second remission transplant to go for a cure while you in healthy and in a CR. Let me know if I can help. We are all in this together. , 59 yr family doc & father of 4, dx 9/05 del 11q unmutated, CD38+, ITP 9/06 failed steroids, IVIG , Rituxan and splenectomy controlled w cyclosporin A & Rituxan combo. RIC MUD HSCT July 1/08 was CR w BMB MRD neg. - lost graft w growing nodes at 6 months, BM involvement and ITP again at 13 months, now controlled w IVIG cyclosporin and recent course of R, mild anemia see http://bkoffman.blogspot.com/ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2011 Report Share Posted February 14, 2011 My husband has 11q and is currently in the CAL101 / Rituxan trial. He is responding very well, with very large nodes almost disappearing in just a week or two. Now we are hoping the R will clean out the blood, and in fact his WBC/ALC went from 122 to 44 in one week. So far he has no side effects and is tolerating everything very well. We are excited, but realize that this is early days for this treatment. He was previously on Rituxan mono therapy from Feb of 2003 until 2010 when the Rituxan did not work on his nodes and marrow anymore. With CAL101, the drop in his nodes overnight is very exciting, and we hope the R has enough punch left in him to bring down the WBC/ALC over the next weeks. He started the trial on January 3. We are cautiously optomistic! Husband dx 2001 at age 48, 11Q, Rituxan 2/2003 to 2010, now CAL101/Rituxan Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 16, 2011 Report Share Posted February 16, 2011 , If you have the time, I would like take up your invitation to call and get your perspective on this disease. In visiting your web link I was disappointed for you that your transplant did not " take " . My doc is recommending a trans after this cycle of BR but with no MUD the most optimistic forecasts I am hearing from the Cord process is 50/50 survival with 11q w/ ATM deletion...Inclined to take my chances and rely on new technology since I am feeling quite well--working, exercising etc--just minor fatigue and node growth. So if you are inclined, would appreciate the chance to talk. Craig On Mon, Feb 14, 2011 at 3:24 PM, Koffman wrote: Craig, As another fellow with 11q del. I can tell you that from my experience, and based on my most recent understanding of the science, if you don't shrink the nodes all the way back to normal, and that includes the ones deep in the gut that only a CT or a very skilled sonogram can find, you are headed fro a short remission. 11q is already notorious for shorter remissions. HDMR + R or O is great for nodes, easy on the marrow, but very immune suppressive in the short term. I have seen long remissions with 11qer with this choice. A trial makes senses, especially as the new kinase inhibitors are very good with nodal disease. AT101 is also good with nodes and except for liver inflammation, seems pretty non-toxic Maybe you should be considering a second remission transplant to go for a cure while you in healthy and in a CR. Let me know if I can help. We are all in this together. , 59 yr family doc & father of 4, dx 9/05 del 11q unmutated, CD38+, ITP 9/06 failed steroids, IVIG , Rituxan and splenectomy controlled w cyclosporin A & Rituxan combo. RIC MUD HSCT July 1/08 was CR w BMB MRD neg. - lost graft w growing nodes at 6 months, BM involvement and ITP again at 13 months, now controlled w IVIG cyclosporin and recent course of R, mild anemia see http://bkoffman.blogspot.com/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.